Viewing Study NCT01512420


Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-03-03 @ 3:35 AM
Study NCT ID: NCT01512420
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2011-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: An Observational Study of Tarceva (Erlotinib) in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer With Wild-Type Epidermal Growth Factor Receptor (EGFR) Gene (WILT)
Sponsor: Hoffmann-La Roche
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Squamous Non-Small Cell Lung Cancer View
Keywords: